Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
LY3819253 +2 More for Coronavirus
Recruiting0 awardsPhase 2 & 3
Columbus, Georgia
This trial will test two drugs, LY3819253 and LY3832479, to see how effective they are against the virus that causes COVID-19. The drugs will be given to participants with early symptoms of COVID-19, and samples will be taken to determine how much virus is in the body at various times. Participation could last about 12 weeks.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service